Arbutus andrachne Extracts Exhibit In Vitro Neuraminidase (N9) Inhibitory Activity: A Potential Herbal Strategy Against Avian Influenza

Read full text Summarise with VIRAT
Authors: Areej Abuhammad, Fatma Ü. Afifi‐Yazar, Nour H. Aboalhaija, Mohammed Hussein Kailani, Mutasem O. Taha, Tamara Sabri, Zahra Fauri, Ismail F. Abaza
Cited by: 0
References: 58

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The rise in emerging viral outbreaks has intensified the need for novel antiviral therapies and highlighted the untapped potential of natural products. Influenza viruses, particularly avian strains, continue to evolve rapidly, yet the antiviral properties of Jordan’s native plants remain largely unexplored. This study focused on avian influenza and screened twelve endemic plant species, using ethanol to selectively extract polar phytochemicals likely to interact with the hydrophilic active site of neuraminidase (NA). Among these, Arbutus andrachne leaf and fruit extracts emerged as potent in vitro inhibitors of recombinant N9 neuraminidase, a key enzyme in influenza replication, with IC50 values of 31.6 µg/mL and 32.9 µg/mL, respectively. LC-MS analysis identified hyperoside as the major shared flavonoid in both extracts, which may contribute to the observed inhibitory activity. These findings support the potential of A. andrachne as a natural source for herbal preparations with antiviral activity.

Fields of Study & Subjects

Medicinal Plant Research Influenza Virus Research Studies Phytochemistry and Biological Activities

Publication details

Journal / source
Life
Volume
16
Issue
4
Pages
560–560
Publication date
29 March 2026
Language
EN